Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial

BACKGROUND: Systemic lupus erythematosus (SLE) is a complex autoimmune disease associated with widespread immune dysregulation and diverse clinical features. Immune abnormalities might be differentially associated with specific organ involvement or response to targeted therapies. We aimed to identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Shipa, Muhammad, Santos, Liliana R, Nguyen, Dao X, Embleton-Thirsk, Andrew, Parvaz, Mariea, Heptinstall, Lauren L, Pepper, Ruth J, Isenberg, David A, Gordon, Caroline, Ehrenstein, Michael R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894756/
https://www.ncbi.nlm.nih.gov/pubmed/36756239
http://dx.doi.org/10.1016/S2665-9913(22)00332-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894756/
https://www.ncbi.nlm.nih.gov/pubmed/36756239
http://dx.doi.org/10.1016/S2665-9913(22)00332-0

Ejemplares similares